news.cision.com

Press Release Free for release on January 20, 2021, at 10.00 am (CET +1) The Next Generation Bittium OmegaSnap™ ECG Electrode Enables Long-term ECG Recordings Oulu, Finland, January 20, 2021 – Bittium, a leading specialist for secure communications, connectivity, and medical technology solutions, launches next-generation Bittium OmegaSnap™ ECG Electrode for the Bittium Faros™ ECG sensors. Bittium OmegaSnap™ is a wearable ECG patch electrode specifically designed for long term ECG recordings. The new electrode is based on the popular Bittium FastFix™ electrode, which has been

Germany extends lock-down with strict measures, Kamux’s car sales continues solely online

Kamux Corporation Press Release 20 January 2021 at 10:00 Germany extends lock-down with strict measures, Kamux’s car sales continues solely online Germany further extends the lock-down which started in December, 2020 and which was already extended until the end of January. According to the current information, the extended lock-down will last until 14 February, 2021. Additionally, based on incidence of infections instructions related to work arrangements and home office working will continue until 15th March. “We’ll continue to do car sales through digital channels and

The New DCH 150-SL Wall Chaser For Diamond Cutting Increases Productivity and is Virtually Dust-Free

Hilti’s diamond cutting portfolio is expanding. Introducing the new DCH 150-SL slitting tool for faster, cleaner and more consistent cuts.For more than 20 years, industry professionals have trusted the DC-SE 20 Wall chaser when it comes to cutting slits for the installation of cables, conduits and pipes in various base materials. How do you replace a legend like the DC-SE 20? After much development, we now have a worthy successor. The new Hilti DCH 150-SL takes slitting to a whole new level, with faster performance, even better handling and virtually dust-free operation. Fast and

New clinical data from 1,055 cranioplasty procedures with OssDsign Cranial PSI continue to show low complication rates

OssDsign AB (publ) (“OssDsign” or the “Company”) today announced that updated outcome data on the use of OssDsignCranial PSI in 1,055 cases of cranioplasty and cranial reconstructions have been made public via the company’s website. After a median follow-up time of 21 months, rate of infections leading to implant removal was 2.1%, which is consistent with the low levels previously presented. All data were collected as part of post-market surveillance of product performance in Europe, US and selected Asian markets in compliance with MEDDEV 2.7/1 rev.4 and MDR 2017/745.Reconstruction of

RNB Retail and Brands AB (publ) announces the result of the written procedure instigated on 11 January 2021

Wed, Jan 20, 2021 08:45 CET

On 11 January 2021 RNB Retail and Brands AB (publ) (the "Issuer") instructed Nordic Trustee & Agency AB (publ) (the "Agent"), agent for the Issuer's up to SEK 600,000,000 senior secured floating rate notes with ISIN SE0010625830 (the "Notes"), to instigate a written procedure (the "Written Procedure") to resolve on certain amendments to the terms and conditions of the Notes (the "Terms and Conditions"). As described in the notice of Written Procedure published by the Issuer and the Agent on11 January 2021 and distributed to holders of the Notes (the "Noteholders"), the purpose of the

Doptelet® (avatrombopag) approved in the EU for treatment of ITP

Doptelet® (avatrombopag) approved in the EU for treatment of ITP Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) today announces that the European Commission (EC) has approved an extension of the indication for Doptelet (avatrombopag) to include the treatment of primary chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins) in all European Union (EU) member states. Immune thrombocytopenia (ITP) is an autoimmune disorder characterised by low numbers of platelets, leading to

Wihlborgs builds new facility for Beckhoff Sweden in Malmö

Wihlborgs has signed an agreement with Beckhoff Automation AB for a new 1,800 m² office building for Beckhoff’s Swedish headquarters in Fosie, Malmö.Beckhoff develops universal and open control and automation solutions that are used in a wide variety of applications ranging from CNC machine tools to intelligent building automation systems. Beckhoff’s Swedish headquarters is already located in Malmö, but the company is set to move in to an entirely new and modern building at Hindbygården 7 adjacent to Inre Ringvägen and Ystadvägen in summer 2022. Beckhoff will lease the entire property in

Scout Gaming launches new jackpot tipping game

Scout Gaming has launched an additional product to their award-winning portfolio. The Pick’em Jackpot game combines traditional sports knowledge with a jackpot.In the Pick’em Jackpot game, players are required to pick the outcome in a given set of matches (home or away team victory, draw) along with predicting the jackpot trigger match score - players will receive a prize if the outcome was predicted correctly. For example, if there are 13 matches which is a default number, players will have to guess correctly in 13, 12, 11, or 10 matches to get a prize. If a player has all correct outcomes

Northmill Bank introduces its third savings account

- Offering one of the highest interests in Sweden with a government deposit guaranteeStockholm, January 20 2021: The neobank Northmill Bank , which has the vision to improve people’s financial life, launches a new 24 months fixed-rate savings account with a 1.35 % annual interest rate and state-provided deposit insurance up to SEK 1,050,000. The introduction of the neobank’s third savings account takes place almost exactly one year after the launch of the first one, and just two months following the membership in RIX (

Changed date for Ratos's Year-End report and conference call to February 8, 2021

On Monday, February 8 2021, Ratos will publish the Year-End report for 2020. The report will be published at approximately 07.00 CET. The date has been changed from the previously communicated date, February 11, as a result of the date for the 2021 Annual General Meeting being brought forward to March 10, 2021.At 09.00 CET on February 8, a telephone conference will be held, participant connection: UK: +44 333 300 9031, SE: +46 8 505 583 50, US: +1 833 526 83 47. The telephone conference will be webcasted live at www.ratos.com where presentation material will be available as soon as the

Invitation to the Volvo Group report on the fourth quarter 2020

The Volvo Group report for the fourth quarter 2020 will be published on February 3, 2021 at 7.20 a.m. CET. There will be a conference call for press and analysts starting at 9.00 a.m. CET.An online presentation of the report, followed by a question-and-answer session, will be broadcast at 9.00 a.m. CET. The Volvo Group will be represented by President and CEO Martin Lundstedt and CFO Jan Ytterberg. To listen to the online conference, please log in here . If you wish to ask questions, please dial the phone number about ten minutes

InCoax receives an additional 3,2 MSEK order from US Fiber/LAN Operator

After the first wave of successful commercial installations in San Diego, Denver and Miami in Q4 2020, the US based Fiber/LAN Operator has decided to expand installations to Chicago, Seattle, Austin, Nashville, and San Francisco, adding to the ongoing roll-out in the initial metropolitan areas. InCoax will thus during Q1 2021 have ongoing rollouts in eight major US metropolitan areas with growth potential. The order will be supplied and invoiced during Q1 2021.The Operator is active in more than 10 metropolitan areas in the US and currently has approximately half a million subscribers. ”

Changes in the KONE Executive Board

KONE Corporation, stock exchange release, January 20, 2021 at 9.30 a.m. EET Changes in the KONE Executive Board Johannes Frände has been appointed Executive Vice President, General Counsel and a member of the Executive Board at KONE as of February 1, 2021. Johannes will be based in Espoo, Finland and will report to Henrik Ehrnrooth, President and CEO, KONE Corporation. Johannes succeeds Klaus Cawén, who has decided to focus on non-executive duties after 38 years of service at KONE. Klaus served as Executive Vice President, M&A and Strategic Alliances, Legal Affairs and has been a

Certain Board members, senior executives and major shareholders have undertaken to subscribe for shares for a total of approx. SEK 15.5 million by exercising warrants of series 2019/2021

Wed, Jan 20, 2021 08:15 CET

The following board members, senior executives and major shareholders in ADDvise Group AB (publ) (“ADDvise”) have irrevocably undertaken to exercise a total of 23,813,195 warrants of series 2019/2021, which corresponds to a total of approximately 55% of the warrants of series 2019 / 2021 (“The Warrants”). The subscription means that ADDvise will receive issue proceeds of at least SEK 15.5 million. The subscription period for the Warrants runs from and including January 25, 2021 until and including February 8, 2021. Holders of Warrants have the right to subscribe for one (1) new share of

Quarterly Report I 20/21

September 2020 – November 2020, Diamyd Medical AB (publ), Fiscal year 2020/2021Figures in parentheses relate to the corresponding period previous financial year. September 1, 2020 – November 30, 2020 · Net result: MSEK 104.9 (-6.8). The increase compared to previous year is a one-off effect of corresponding MSEK 117.5 due to profit from divestment of shares in Companion Medical, Inc. · Result per share: SEK 1.5 (-0.1) · Cash flow from operating activities: MSEK -14.1 (-6.1) · Cash and cash equivalents at November 30, 2020: MSEK 173.0 (50.6) Significant events first

Christian Cederholm appointed Head of Patricia Industries

Wed, Jan 20, 2021 08:15 CET

Christian Cederholm, currently Co-Head of Patricia Industries, has been appointed Head of Patricia Industries. Noah Walley, currently also Co-Head of Patricia Industries, will retire from full-time employment and assume a role as Senior Advisor to Patricia Industries and Investor. “We formed Patricia Industries six years ago in order to accelerate the efforts to develop our wholly owned subsidiaries. During Christian’s and Noah’s joint leadership since 2017, Patricia Industries has invested in three new platform companies on top of several add-on investments within the existing

Enhertu approved in the EU for the treatment of HER2-positive metastatic breast cancer

20 January 2021 07:00 GMT Enhertu approved in the EU for the treatmentof HER2-positive metastatic breast cancer Approval based on DESTINY-Breast01 Phase II trial which showed clinically meaningful and durable responses in patients with previously treated disease AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)'s Enhertu (trastuzumab deruxtecan) has been granted conditional approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-

Invitation to conference call with web presentation of AcadeMedia's quarterly report for July – December 2020/21

AcadeMedia's quarterly report for July - December 2020/21 will be published at 08:00 CET on 3 February. A web-cast telephone conference will be held at 09:30 CET the same day, where CEO Marcus Strömberg and CFO Katarina Wilson will present the report. The presentation will be held in English and can be followed on the web or over the phone. It will be followed by a Q&A session. To participate in the conference call, and thereby be able to ask questions, call one of the following numbers ten minutes before the start of the call:SE: +46 8 50558353UK: +44 33 3300 9034US: 1 833 5268

Handelsbanken’s year-end report for January – December 2020 will be presented on Wednesday, 3 February

Handelsbanken publishes its year-end report for January – December 2020 at 7:00 a.m. CET on Wednesday, 3 February. The Group Chief Executive Carina Åkerström will present the Bank’s year-end report in Stockholm at 9:00 a.m. CET. The presentation will be held in Swedish, with simultaneous interpretation into English. A link to the presentation will be available at handelsbanken.com/ir. A conference call for investors and analysts will be held at 11:00 a.m. CET in which Group Chief Executive, Carina Åkerström, and CFO, Carl Cederschiöld, will present the report. UK number: +44 333

Essity launches absorbent underwear for menstruation and incontinence

Hygiene and health company Essity is launching new ranges of washable absorbent underwear within its feminine care and incontinence products categories. The underwear offers invisible protection for up to eight hours, providing users with a more sustainable option than disposable protection.[Intimawear by Libresse]In Essity’s incontinence products category, TENA Silhouette Washable Absorbent Underwear is being launched for women with light bladder weakness and with a focus on discretion. In Essity’s feminine care category, a line of period underwear is being launched called intimawear under

Bexmarilimab (Clevegen) development update

· Cholangiocarcinoma becomes fifth tumour cohort to show early signs of efficacy · Increased bexmarilimab dosing schedule and high baseline regulatory T cell count associated with clinical benefit · High levels of soluble Clever-1 observed in MATINS patients · Soluble Clever-1 has the capacity to suppress T cell activation · Increased bexmarilimab dosing frequency to counter high levels of soluble Clever-1 underway Company announcement, 20 January 2021 at 9.00 AM PM (EEST) Insider information TURKU, FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON)

Heimstaden issues senior unsecured subsequent bonds of SEK 1,400 million, announces results from tender offer and gives notice of early redemption of outstanding 2021 notes

This press release should be read in conjunction with the press release published by Heimstaden on 13 January 2021 at 09:34 CET and the related Tender Information Document (as defined in and attached to that press release). No offer or invitation to acquire or sell any securities is being made pursuant to this announcement. NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED

Calliditas announces clinical development plan for setanaxib and comments on data from Part A of NefIgArd study at today´s R&D Day